Business / Finance

RSS

Fresenius Medical Care announces acquisition of Hema Metrics assets related to Crit-Line system

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced the acquisition of all assets of Hema Metrics LLC related to its Crit-Line system.

8 Mar 2011

Sectra’s third quarter net sales increase 13.9% to SEK 229.1 million

IT and medical technology company Sectra continues to expand and the number of mammography systems delivered rose 50% during the third quarter compared with the corresponding quarter in 2009/2010. However, the performance of the Swedish krona had a negative impact on the Group's earnings.

8 Mar 2011

Humana joins with iCan to offer new individual healthcare plans

Humana Inc. (NYSE: HUM) has teamed with the iCan Benefit Group to offer a new line of discounted products for individual consumers. Effective immediately, people can access a variety of discounted packages that include dental, vision and pharmacy products.

8 Mar 2011

Aerie Pharmaceuticals closes $30 million Series B financing

Aerie Pharmaceuticals, Inc, a biotechnology company focused on the discovery and development of medical innovations in ophthalmology, today announced the closing of a $30 million Series B financing.

7 Mar 2011

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

7 Mar 2011

RadNet executes definitive agreement to acquire imaging centers in Maryland

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 201 fully-owned and operated outpatient imaging centers, today reported it has executed a definitive agreement to acquire five multi-modality imaging centers in Maryland from Diagnostic Health Corporation for an undisclosed combination of cash and the assumption of certain liabilities.

7 Mar 2011

Mangrove Partners comments that its analysis inaccurately portrayed in CPEX's letter to stockholders

Mangrove Partners, owners of 149,373 shares representing approximately 5.71% of the outstanding shares of CPEX Pharmaceuticals, Inc, believes its analysis and intentions were inaccurately portrayed in CPEX's March 2, 2011 letter to stockholders, which appears to use scare tactics in order to pressure stockholders into accepting an inadequate price for their shares.

5 Mar 2011

Angiotech extends offer to exchange new senior floating rate notes for Existing Floating Rate Notes

Angiotech Pharmaceuticals, Inc. today announced that it has extended its offer to exchange new senior floating rate notes due 2013 for all of its outstanding Senior Floating Rate Notes due 2013 to 11:59 p.m. New York City time on March 30, 2011.

5 Mar 2011

Advaxis CEO issues statement to shareholders regarding recent common stock transition

Thomas A. Moore, chairman and CEO of Advaxis, Inc., the live, attenuated Listeria monocytogenes vaccine company, has issued the following statement to shareholders regarding the recent transition to the OTCQB from the OTCBB:

5 Mar 2011

BATSK advances 0.3% stock this week in the U.S.

BATS Global Markets, a global stock market operator, reports the BATS 1000 Index advanced 0.3% for the week ending March 4 in the U.S. The S&P 500 Index was up 0.1% for the same period.

5 Mar 2011

MedQuist extends exchange offer for all outstanding shares of common stock

MedQuist Holdings Inc., a leading provider of integrated clinical documentation solutions for the U.S. healthcare system, today announced that it has extended the expiration date for its exchange offer for all issued and outstanding shares of MedQuist Inc. common stock until 5:00 p.m., New York City time, on Friday, March 11, 2011, unless further extended or earlier terminated.

5 Mar 2011

Agenus receives letter from Listing Qualifications Staff of The NASDAQ Stock Market

Agenus Inc. announced today that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC on March 3, 2011 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.

5 Mar 2011

Shares of Bacterin's common stock receive approval for listing on NYSE Amex

Bacterin International Holdings, Inc., a creator and developer of revolutionary bone graft material and anti-infective coatings for medical applications, today announced that its common stock has been approved for listing on the NYSE Amex and has chosen Knight Capital Group as its designated market maker.

5 Mar 2011

Pending merger transaction between Grifols, Talecris has been extended

Grifols S.A. and Talecris Biotherapeutics Holdings Corp. today announced that the outside date under their merger agreement for closing their pending merger transaction has been extended to June 30, 2011 (from March 6, 2011).

5 Mar 2011

Biosante to purchase $25.1 million shares of common stock in registered direct offering

BioSante Pharmaceuticals, Inc. today announced that it has received commitments from several institutional investors to purchase $25.1 million of securities in a registered direct offering.

5 Mar 2011

Skilled Healthcare Group to transfer operations of five indirect subsidiaries to Brius Healthcare

Skilled Healthcare Group, Inc. today announced that five of its indirect subsidiaries that operate skilled nursing facilities in northern California have entered into an agreement to transfer their operations to Brius Healthcare, LLC and expects the transfer to be completed in April 2011 following the receipt of necessary regulatory approvals.

5 Mar 2011

Centric Health terminates acquisition of DNPI Group

Centric Health Corporation, Canada's leading diversified healthcare services company, today announced that in terms of previous announcements dated December 22, 2010 and January 12, 2011, it has terminated discussions for the acquisition of Dedicated National Pharmacies Inc., Methadrug Clinic Limited and Union Medical Pharmacy Inc. from the court-appointed receiver of the DNPI Group.

5 Mar 2011

Sequel Youth and Family Services acquires Camelot System of Care

Levine Leichtman Capital Partners, a Los Angeles-based private equity firm, announced today that Sequel Youth and Family Services, a portfolio company of Levine Leichtman Capital Partners IV, L.P., has completed the strategic acquisition of Camelot System of Care.

5 Mar 2011

Questcor Pharmaceuticals appoints BDO to audit its consolidated financial statements

Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.

5 Mar 2011

Summer Street Research announces recent closing of financing for IMUC

Summer Street Research Partners is pleased to announce the recent closing of a financing for ImmunoCellular Therapeutics, Ltd., a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers.

5 Mar 2011

Business / Finance

Fresenius Medical Care announces acquisition of Hema Metrics assets related to Crit-Line system

Sectra’s third quarter net sales increase 13.9% to SEK 229.1 million

Humana joins with iCan to offer new individual healthcare plans

Aerie Pharmaceuticals closes $30 million Series B financing

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

RadNet executes definitive agreement to acquire imaging centers in Maryland

Mangrove Partners comments that its analysis inaccurately portrayed in CPEX's letter to stockholders

Angiotech extends offer to exchange new senior floating rate notes for Existing Floating Rate Notes

Advaxis CEO issues statement to shareholders regarding recent common stock transition

BATSK advances 0.3% stock this week in the U.S.

MedQuist extends exchange offer for all outstanding shares of common stock

Agenus receives letter from Listing Qualifications Staff of The NASDAQ Stock Market

Shares of Bacterin's common stock receive approval for listing on NYSE Amex

Pending merger transaction between Grifols, Talecris has been extended

Biosante to purchase $25.1 million shares of common stock in registered direct offering

Skilled Healthcare Group to transfer operations of five indirect subsidiaries to Brius Healthcare

Centric Health terminates acquisition of DNPI Group

Sequel Youth and Family Services acquires Camelot System of Care

Questcor Pharmaceuticals appoints BDO to audit its consolidated financial statements

Summer Street Research announces recent closing of financing for IMUC

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News